Haemonetics (HAE) Retained Earnings (2010 - 2026)

Haemonetics has reported Retained Earnings for 17 years, with the latest figure at $311.5 million in Q2 2026.

• On a quarterly basis, Retained Earnings fell 12.51% year-over-year to $311.5 million in Q2 2026; TTM through Jun 2026 was $311.5 million, a 12.51% decrease from a year earlier, with the FY2026 full-year figure at $279.3 million, down 20.68% from the prior year.
• Retained Earnings was $311.5 million for Q2 2026 at Haemonetics, up from $279.3 million in the prior quarter.
• The five-year high for Retained Earnings was $392.2 million in Q4 2024, with the low at -$26.0 million in Q2 2022.
• Average Retained Earnings over 5 years is $290.9 million, with a median of $311.5 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2026: Retained Earnings soared 1075.45% in 2023, then fell 20.68% in 2026.
• Over 5 years, Retained Earnings stood at $223.8 million in 2022, then soared by 51.98% to $340.1 million in 2023, then rose by 15.33% to $392.2 million in 2024, then fell by 2.84% to $381.1 million in 2025, then slipped by 18.26% to $311.5 million in 2026.
• The last three Retained Earnings figures came in at $311.5 million (Q2 2026), $279.3 million (Q1 2026), and $381.1 million (Q4 2025), per Business Quant data.